Literature DB >> 20334355

Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer.

Andrew J Simnick1, C Alexander Valencia, Rihe Liu, Ashutosh Chilkoti.   

Abstract

Multivalency is the increase in avidity resulting from the simultaneous interaction of multiple ligands with multiple receptors. This phenomenon, seen in antibody-antigen and virus-cell membrane interactions, is useful in designing bioinspired materials for targeted delivery of drugs or imaging agents. While increased avidity offered by multivalent targeting is attractive, it can also promote nonspecific receptor interaction in nontarget tissues, reducing the effectiveness of multivalent targeting. Here, we present a thermal targeting strategy--dynamic affinity modulation (DAM)--using elastin-like polypeptide diblock copolymers (ELP(BC)s) that self-assemble from a low-affinity to high-avidity state by a tunable thermal "switch", thereby restricting activity to the desired site of action. We used an in vitro cell binding assay to investigate the effect of the thermally triggered self-assembly of these ELP(BC)s on their receptor-mediated binding and cellular uptake. The data presented herein show that (1) ligand presentation does not disrupt ELP(BC) self-assembly; (2) both multivalent ligand presentation and upregulated receptor expression are needed for receptor-mediated interaction; (3) increased size of the hydrophobic segment of the block copolymer promotes multivalent interaction with membrane receptors, potentially due to changes in the nanoscale architecture of the micelle; and (4) nanoscale presentation of the ligand is important, as presentation of the ligand by micrometer-sized aggregates of an ELP showed a low level of binding/uptake by receptor-positive cells compared to its presentation on the corona of a micelle. These data validate the concept of thermally triggered DAM and provide rational design parameters for future applications of this technology for targeted drug delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20334355      PMCID: PMC2862343          DOI: 10.1021/nn901732h

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  22 in total

Review 1.  Integrin signaling.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Science       Date:  1999-08-13       Impact factor: 47.728

2.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides.

Authors:  D E Meyer; A Chilkoti
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

3.  Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system.

Authors:  Dan E Meyer; Ashutosh Chilkoti
Journal:  Biomacromolecules       Date:  2002 Mar-Apr       Impact factor: 6.988

Review 4.  Alzheimer's disease and angiogenesis.

Authors:  Anthony H Vagnucci; William W Li
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

5.  High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

Authors:  G P Adams; R Schier; A M McCall; H H Simmons; E M Horak; R K Alpaugh; J D Marks; L M Weiner
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

Review 6.  For the clinical application of thermochemotherapy given at mild temperatures.

Authors:  M Urano; M Kuroda; Y Nishimura
Journal:  Int J Hyperthermia       Date:  1999 Mar-Apr       Impact factor: 3.914

7.  Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.

Authors:  D Raucher; A Chilkoti
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

8.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

9.  Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy.

Authors:  Matthew R Dreher; Drazen Raucher; Narayanan Balu; O Michael Colvin; Susan M Ludeman; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

10.  Cell adhesion and motility depend on nanoscale RGD clustering.

Authors:  G Maheshwari; G Brown; D A Lauffenburger; A Wells; L G Griffith
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  28 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 2.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

Review 3.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

Review 4.  Controlled release from recombinant polymers.

Authors:  Robert Price; Azadeh Poursaid; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

5.  Fusions of elastin-like polypeptides to pharmaceutical proteins.

Authors:  Wafa Hassouneh; Sarah R MacEwan; Ashutosh Chilkoti
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

6.  Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

Authors:  Christopher J Cheng; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

7.  In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide.

Authors:  Andrew J Simnick; Miriam Amiram; Wenge Liu; Gabi Hanna; Mark W Dewhirst; Christopher D Kontos; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2011-07-08       Impact factor: 9.776

Review 8.  Drug delivery to solid tumors by elastin-like polypeptides.

Authors:  Jonathan R McDaniel; Daniel J Callahan; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2010-05-27       Impact factor: 15.470

Review 9.  Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.

Authors:  Jordan Despanie; Jugal P Dhandhukia; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2015-11-11       Impact factor: 9.776

10.  Engineering the Architecture of Elastin-Like Polypeptides: From Unimers to Hierarchical Self-Assembly.

Authors:  Soumen Saha; Samagya Banskota; Stefan Roberts; Nadia Kirmani; Ashutosh Chilkoti
Journal:  Adv Ther (Weinh)       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.